Kentucky Retirement Systems Insurance Trust Fund cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 9.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,751 shares of the company’s stock after selling 379 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Henry Schein were worth $273,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in HSIC. Swedbank AB acquired a new position in shares of Henry Schein during the first quarter worth about $215,998,000. ING Groep NV purchased a new position in shares of Henry Schein during the third quarter worth approximately $63,226,000. Thompson Siegel & Walmsley LLC purchased a new position in shares of Henry Schein during the second quarter worth approximately $46,683,000. SG Americas Securities LLC grew its position in shares of Henry Schein by 1,622.3% during the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after acquiring an additional 432,187 shares during the last quarter. Finally, Private Management Group Inc. purchased a new position in shares of Henry Schein during the third quarter worth approximately $24,176,000. 96.62% of the stock is owned by institutional investors and hedge funds.
Henry Schein Trading Up 1.3 %
Shares of HSIC stock opened at $74.84 on Wednesday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock has a market cap of $9.33 billion, a P/E ratio of 30.80, a P/E/G ratio of 1.97 and a beta of 0.87. The business has a fifty day simple moving average of $70.55 and a 200-day simple moving average of $69.66. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on the stock. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research restated an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. UBS Group cut their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Robert W. Baird cut their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Finally, JPMorgan Chase & Co. cut their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $78.89.
Get Our Latest Stock Analysis on HSIC
Insider Activity
In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.14% of the company’s stock.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Following Congress Stock Trades
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.